Xiangbin Zhong
About
Xiangbin Zhong is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery.
According to data from OpenAlex, Xiangbin Zhong has authored 49 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Surgery. Recurrent topics in Xiangbin Zhong's work include Cardiovascular Function and Risk Factors (11 papers), Blood Pressure and Hypertension Studies (9 papers) and Heart Rate Variability and Autonomic Control (5 papers). Xiangbin Zhong is often cited by papers focused on Cardiovascular Function and Risk Factors (11 papers), Blood Pressure and Hypertension Studies (9 papers) and Heart Rate Variability and Autonomic Control (5 papers). Xiangbin Zhong collaborates with scholars based in China, United States and Trinidad and Tobago. Xiangbin Zhong's co-authors include Xiaodong Zhuang, Xinxue Liao, Yifen Lin, Shaozhao Zhang, Zhenyu Xiong, Xiaomin Ye, Rihua Huang, Yue Leon Guo, Huimin Zhou and Xiuting Sun and has published in prestigious journals such as Journal of the American College of Cardiology, Diabetes Care and Journal of Environmental Management.
In The Last Decade
Xiangbin Zhong
44 papers receiving 389 citations
Peers
Xiangbin Zhong
J. Rafael Jiménez-Flores Mexico
Elisa T. Lee United States
Minerva Granado-Casas Spain
Andrew Ryabikov Russia
Junyu Pei China
Sneha Annie Sebastian United States
Camila Ragne Torreglosa Brazil
Paraskevi Voidonikola Greece
Marit de Jong Netherlands
Karin Skov Denmark
Citations per year, relative to Xiangbin Zhong Xiangbin Zhong (= 1×)
peers
J. Rafael Jiménez-Flores
Countries citing papers authored by Xiangbin Zhong
Since
Specialization
Citations
This map shows the geographic impact of Xiangbin Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbin Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbin Zhong more than expected).
Fields of papers citing papers by Xiangbin Zhong
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Xiangbin Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbin Zhong. The network helps show where Xiangbin Zhong may publish in the future.
Co-authorship network of co-authors of Xiangbin Zhong
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangbin Zhong. A scholar is included among the top collaborators of Xiangbin Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangbin Zhong. Xiangbin Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ye, Xiaomin, Shaozhao Zhang, Xiangbin Zhong, et al.. (2025). Real-World Assessment of the Association Between PCSK9i Adherence and LDL Reduction and Variability in a Chinese Clinical Practice. Clinical Epidemiology. Volume 17. 537–546.
2.
Wu, Meiling, et al.. (2025). Spatiotemporal impacts of scientific and technological innovation and industry chain resilience on ecological Efficiency: Evidence from 284 Chinese cities. Journal of Environmental Management. 384. 125532–125532.
3.
Wu, Shan, et al.. (2024). Interactions of genetic variations in FAS, GJB2 and PTPRN2 are associated with noise-induced hearing loss: a case-control study in China. BMC Medical Genomics. 17(1). 18–18.
4.
Wu, Shangong, et al.. (2023). Astragaloside IV ameliorate acute alcohol-induced liver injury in mice via modulating gut microbiota and regulating NLRP3/caspase-1 signaling pathway. Annals of Medicine. 55(1). 2216942–2216942.
5.
Huang, Yiquan, Shaozhao Zhang, Menghui Liu, et al.. (2023). Interplay of heart rate variability and resting heart rate on mortality in type 2 diabetes. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(1). 102930–102930.
6.
Wu, Shan, et al.. (2023). The association between road traffic noise and type 2 diabetes: a systematic review and meta-analysis of cohort studies. Environmental Science and Pollution Research. 30(14). 39568–39585.
7.
Zhong, Xiangbin, Menghui Liu, Shaozhao Zhang, et al.. (2023). Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus. Journal of Diabetes Investigation. 14(3). 441–451.
8.
Wu, Shangong, et al.. (2023). Effect of chronic noise exposure on glucose and lipid metabolism in mice via modulating gut microbiota and regulating CREB/CRTC2 and SREBP1/SCD pathway. Ecotoxicology and Environmental Safety. 270. 115887–115887.
9.
Zhang, Gaoxing, Shaozhao Zhang, Yifen Lin, et al.. (2022). Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention. Global Heart. 17(1). 14–14.
10.
Lin, Yifen, Jianqiu Kong, Ting Tian, et al.. (2022). Identification of Novel Phenotypes Correlated with CKD: A Phenotype-Wide Association Study. International Journal of Medical Sciences. 19(13). 1920–1928.
11.
Liu, Menghui, Rihua Huang, Lin Xu, et al.. (2022). Cardiovascular effects of intensive lifestyle intervention in adults with overweight/obesity and type 2 diabetes according to body weight time in range. EClinicalMedicine. 49. 101451–101451.
12.
Lin, Yifen, Xiangbin Zhong, Zhenyu Xiong, et al.. (2021). Intensity of Glycemic Exposure in Early Adulthood and Target Organ Damage in Middle Age: The CARDIA Study. Frontiers in Physiology. 12. 614532–614532.
13.
Xiong, Zhenyu, Jiaying Li, Yifen Lin, et al.. (2021). Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Cardiac Structure and Function at Midlife: The CARDIA Study. Frontiers in Cardiovascular Medicine. 8. 687054–687054.
14.
Guo, Yue Leon, Huimin Zhou, Xiuting Sun, et al.. (2021). Short-chain fatty acids combined with intronic DNA methylation of HIF3A: Potential predictors for diabetic cardiomyopathy. Clinical Nutrition. 40(6). 3708–3717.
15.
Lin, Yifen, Xiangbin Zhong, Menghui Liu, et al.. (2021). Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. Cardiovascular Drugs and Therapy. 36(2). 323–331.
16.
Zhang, Shaozhao, Huimin Zhou, Menghui Liu, et al.. (2020). A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft. European Journal of Clinical Investigation. 51(1). e13405–e13405.
17.
Zhang, Ling, Xiuting Sun, Lizhen Liao, et al.. (2019). Effectiveness of blood pressure–lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Journal of Clinical Hypertension. 21(12). 1813–1820.
18.
Yang, Daya, Xin He, Shaozhao Zhang, et al.. (2019). Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials. Cardiovascular Diabetology. 18(1). 47–47.
19.
Zhuang, Xiaodong, Daya Yang, Shaozhao Zhang, et al.. (2018). GW29-e0476 Deep Phenotyping the Cardiovascular Disease in National Health and Nutrition Examination Survey 1999-2014: Presenting the Full Picture. Journal of the American College of Cardiology. 72(16). C207–C207.
20.
Sun, Xiuting, Yue Leon Guo, Zhiqiang Nie, et al.. (2018). Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT). Clinical Research in Cardiology. 108(3). 273–281.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by J. Rafael Jiménez-Flores Breakdown of academic impact, for papers by Elisa T. Lee Breakdown of academic impact, for papers by Minerva Granado-Casas Breakdown of academic impact, for papers by Andrew Ryabikov Breakdown of academic impact, for papers by Junyu Pei Breakdown of academic impact, for papers by Sneha Annie Sebastian Breakdown of academic impact, for papers by Camila Ragne Torreglosa Breakdown of academic impact, for papers by Paraskevi Voidonikola Breakdown of academic impact, for papers by Marit de Jong Breakdown of academic impact, for papers by Karin Skov